Sign in

CIK 0001650648 · Non-accelerated filer<br>Smaller reporting company

4D Molecular Therapeutics, Inc.

Sign in to watch
Ticker
FDMT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
473506994
Phone
5105052680
Business address
5858 HORTON STREET #455, EMERYVILLE, CA, 94608
Former names
4D Molecular Therapeutics Inc., 4D Molecular Therapeutics Inc
  1. 4 Option exercise Chief Financial Officer acquired 1,000 shares (option exercise)
  2. DEFA14A Proxy Proxy Materials
  3. DEF 14A Proxy Proxy Statement
  4. S-8 Other Securities Offered to Employees in Benefit Plans
  5. 10-K Report Annual Report
  6. 8-K Event Results of operations
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. SC 13G/A Stake Amended Statement of Ownership
  11. SC 13G Stake Amended Statement of Ownership
  12. SC 13G Stake Amended Statement of Ownership
  13. SC 13G/A Stake Amended Statement of Ownership
  14. SC 13G Stake Amended Statement of Ownership
  15. SC 13G Stake Amended Statement of Ownership
  16. SC 13G Stake Amended Statement of Ownership
  17. SC 13G Stake Amended Statement of Ownership
  18. 4 Open-market buy 10% owner bought 1,100,000 shares at $23.00 ($25,300,000)
  19. 4 Open-market buy Director bought 100,000 shares at $23.00 ($2,300,000)
  20. 4 Open-market buy See Remarks bought 4,347 shares at $23.00 ($99,981)

Page 20 of 23 · 442 filings